We are live on
!
Find out more
RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
23.37%
This Fund
S&P 500
This Quarter
Est. Return
+1%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$791M
AUM Growth
+$27.8M
(+3.6%)
Cap. Flow
+$28.5M
Cap. Flow
% of AUM
3.61%
Top 10 Holdings %
Top 10 Hldgs %
34.56%
Holding
211
New
9
Increased
71
Reduced
95
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$3.56M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$3.52M |
| 3 |
Novartis
NVS
|
+$3.2M |
| 4 |
AptarGroup
ATR
|
+$3.16M |
| 5 |
Walt Disney
DIS
|
+$3.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$7.36M |
| 2 |
CVS Health
CVS
|
+$2.47M |
| 3 |
HOLX
Hologic
HOLX
|
+$1.61M |
| 4 |
Perrigo
PRGO
|
+$1.1M |
| 5 |
Tennant Co
TNC
|
+$960K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.56% |
| 2 | Technology | 21.15% |
| 3 | Industrials | 13.82% |
| 4 | Financials | 10.46% |
| 5 | Communication Services | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Royal Caribbean
RCL
$82.2B
| $577K | 0.07% |
4,900
| – | – |
|
127
Medtronic
MDT
$115B
| $548K | 0.07% |
6,833
+300
| +5% | +$24.7K |
|
128
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
| $545K | 0.07% |
17,508
+80
| +0.5% | +$2.57K |
|
129
Becton Dickinson
BDX
$48.9B
| $540K | 0.07% |
2,553
-310
| -11% | -$67.9K |
|
130
Tesla
TSLA
$1.28T
| $538K | 0.07% |
30,300
+3,780
| +14% | +$83.1K |
|
131
Eli Lilly
LLY
$1.09T
| $511K | 0.06% |
6,606
+152
| +2% | +$12.2K |
|
132
Sprouts Farmers Market
SFM
$7.81B
| $501K | 0.06% |
21,365
-2,150
| -9% | -$55.1K |
|
133
General Mills
GIS
$20.1B
| $499K | 0.06% |
11,070
+200
| +2% | +$10.8K |
|
134
Vanguard Morningstar Growth ETF
VUG
$229B
| $488K | 0.06% |
20,628
-450
| -2% | -$11K |
|
135
Stanley Black & Decker
SWK
$15.4B
| $470K | 0.06% |
3,070
-400
| -12% | -$64.9K |
|
136
Applied Materials
AMAT
$437B
| $466K | 0.06% |
8,375
-586
| -7% | -$32.6K |
|
137
Welltower
WELL
$165B
| $464K | 0.06% |
8,532
-3,098
| -27% | -$175K |
|
138
iShares S&P 500 Value ETF
IVE
$49.9B
| $459K | 0.06% |
4,197
-700
| -14% | -$80K |
|
139
iShares Russell 1000 Growth ETF
IWF
$128B
| $454K | 0.06% |
13,336
-400
| -3% | -$14K |
|
140
Boston Scientific
BSX
$74B
| $444K | 0.06% |
16,267
+800
| +5% | +$21.7K |
|
141
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
| $420K | 0.05% |
3,098
+15
| +0.5% | +$2.1K |
|
142
Crane NXT
CXT
$2.91B
| $417K | 0.05% |
12,956
| – | – |
|
143
Qualcomm
QCOM
$170B
| $417K | 0.05% |
7,531
-1,212
| -14% | -$77.2K |
|
144
DXC Technology
DXC
$1.68B
| $412K | 0.05% |
4,740
-1,315
| -22% | -$115K |
|
|
KSU
145
DELISTED
Kansas City Southern
KSU
| $412K | 0.05% |
3,750
| – | – |
|
146
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
| $406K | 0.05% |
1,188
-23
| -2% | -$8K |
|
147
Phillips 66
PSX
$89.2B
| $404K | 0.05% |
4,208
-40
| -0.9% | -$3.89K |
|
148
iShares MSCI Emerging Markets ETF
EEM
$30.4B
| $400K | 0.05% |
+8,277
| New | +$406K |
|
149
Mettler-Toledo International
MTD
$28.7B
| $394K | 0.05% |
686
-10
| -1% | -$6.29K |
|
150
Enterprise Products Partners
EPD
$81.8B
| $392K | 0.05% |
15,996
-1,800
| -10% | -$47.9K |
|
Similar funds
SC
CAM
TCM
RCM
LGM
MYAM
NIM
C
Reynders McVeigh Capital Management's Q1 2018 Portfolio in Review
As of Q1 2018, Reynders McVeigh Capital Management held 211 positions worth $791M, up 3.6% from $763M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Reynders McVeigh Capital Management deployed $28.5M of net new capital in Q1 2018, opening 9 new positions and adding to 71 existing holdings. Its largest new stake was Teladoc Health: 94,360 shares worth $3.8M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Procter & Gamble, an estimated $7.36M trimmed.
- Reynders McVeigh Capital Management's largest Q1 2018 buy was Teladoc Health: 94,360 shares worth $3.8M.
- Reynders McVeigh Capital Management added most to Alphabet (Google) Class A in Q1 2018, an estimated $3.52M increase.
- Reynders McVeigh Capital Management's biggest Q1 2018 reduction was Procter & Gamble, cutting an estimated $7.36M.
- Reynders McVeigh Capital Management fully exited Accenture in Q1 2018, selling an estimated $723K.
- Reynders McVeigh Capital Management's ten largest holdings make up 35% of its $791M portfolio in Q1 2018.
- Reynders McVeigh Capital Management opened 9 new positions and closed 14 in Q1 2018.
- Reynders McVeigh Capital Management's portfolio value rose 3.6% quarter-over-quarter to $791M.
Based on Reynders McVeigh Capital Management's 13F filing for Q1 2018, filed 3 May 2018.